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Response to Letter to the Editor: ‘Assessing the quality of randomization and
allocation concealment’First of all we want to thank Dr Berger for his letter and his kind
words concerning our paper. Dr Berger makes a valid point in ques-
tioning the validity of randomization and allocation concealment in
the trials included in Vavken and Samartzis1.
Dr Berger is absolutely right to point out that even computer-
generated randomization sequences can be predicted, especially
when patient allocation is randomized in blocks, and are thus just
as predictable as alternating allocation. However, we granted the
included studies the beneﬁt of the doubt since decryption of
computer-generated block sequences requires a willful act of trans-
gression against the rules of scientiﬁc conduct. Alternating alloca-
tion or allocation by date is obvious to everyone without code
breaking and invites selection bias.
Another related problem is to maintain allocation concealment.
The experimental treatment, autologous chondrocyte implanta-
tion, requires two operations, one being a (mini) open procedure,
as opposed to the control treatments (both single, arthroscopic
procedures). Theoretically, blinding of patients and assessor could
be achieved if all patients underwent two “procedures” with
a sham operation and/or equally big skin incisions for the control
groups. Such methods have been used in other studies before
(e.g., Refs. 2, 3), but are reluctantly employed by many surgeons
and are associated with ethical questions due to the perioperative
risk even of sham procedures.
In summary, there are two interconnected problems, establish-
ment and maintenance of allocation concealment, that deserve
more attention4. Obviously there are “mitigating circumstances”
in some cases, but for most studies it is possible to allocate and
assess patients blindly and both investigators and journal editors
should try to identify and point out such possibilities.1063-4584/$ – see front matter  2010 Osteoarthritis Research Society International. Pu
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